Viewing Study NCT01488318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2026-03-05 @ 12:53 PM
Study NCT ID: NCT01488318
Status: TERMINATED
Last Update Posted: 2018-01-05
First Post: 2011-11-30
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Sponsor: Julie E. Bauman, MD, MPH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma Of The Head And Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cetuximab View
None Dasatinib View
None Squamous Cell View
None Head and Neck View
None After Cetuximab Containing Chemoradiotherapy View
None Recurrent View
None Metastatic View